RED HOT Contributors


STAT Plus: Cancer docs oppose ‘right to try’ laws over concerns about unintended harms



ile this under “right to oppose.”

In a significant development, the American Society of Clinical Oncology has become the first major medical society to come out against the burgeoning “right to try” movement, which is pursuing federal and state legislation to hasten access to experimental drugs

This is a STAT Plus article and is only available to STAT Plus subscribers.
To read the full story, subscribe to STAT Plus or log in to your account.
Good news: your first 30 days are on us.


We Support OUR Contributors

Get Our Newsletter

 Receive podcast updates
Exclusive insights
Patient Engagement Tips from industry experts
We hate SPAM as much as you do and promise to keep your email address safe.
  • Subscribe to the Podcast